John Chisholm
Analyst · Stephens. Please go ahead
Thank you, Rich. Thank you all for joining today's call which is being hosted from our new global research and innovation headquarters in Houston. Joining me today is Rich Walton, our Chief Financial Officer who you just heard from; Josh Snively, Florida Chemical President and Executive Vice President of Research and Innovation; and Robert Bodnar, Executive Vice President, Performance and Transformation Officer. I will begin by giving a summary of our quarterly results and attempt to add some color regarding current operations as well as a sense of our future, followed by Rich who will share our fourth quarter highlights and provide additional financial context. Robert will then talk about our work with data and analytics and I will end with some closing remarks before taking your questions. Before we get into the numbers, I will just briefly mention that during the fourth quarter of 2016 we confirmed the strategic repositioning of our enterprise, playing to the strengths of our core businesses in energy, chemistry and consumer and industrial chemistry. We are in the process of divesting our joint technologies and production technologies segment, and as Rich will explain, these businesses are now classified as discontinued operations. Given for some of the complexity of this accounting treatment, if we don’t answer the questions in the type of detail you would like, we will be glad to take one-on-one calls next week to give you further explanation. All of the results we will share today are for our continuing operations which consist of our energy chemistry technologies and consumer and industrial chemistry technology segments. Flotek's revenue was up 9.7% sequentially and down 2.6% year-over-year, a remarkable outcome in the face of a 43% drop in completion activity in 2016 according to the U.S. EIA, which also followed a 38% drop from the previous year. For the full year, revenue was $262.8 million compared with $270 million from 2015. Results were in line with expectations we outlined in December 2016. In 2016, a key part of our business strategy focused on expanding our global footprint. For the first time in Q4, we shipped products to China, the Ukraine and Iraq, extending the reach and application of our technology to potentially key growth markets. We see a meaningful opportunity for Flotek to continue to expand globally. As part of this global opportunity, I was recently appointed to the board of directors of Anton Oilfield Services Group based in China, an important business partner for Flotek. Anton has operations in the Middle East and the Americas in addition to China and it's worth noting that Schlumberger also holds a significant investment in Anton. I see this board position as complementary to my responsibilities at Flotek as it enables me to help guide the way our technology is used in a region that is currently witnessing intense innovation and growth in the oil and gas sector. It also gives me a new vantage point to observe the challenges and needs of producers in these key regions and extend our network. This partnership is mutually beneficial and I am honored to be included on their board. Turning to our businesses, we reported continued strong results from energy chemistry technologies, which includes our patented suite of complex nano-Fluid products. Sequentially, quarterly revenues increased 22.4%, primarily because of a 12.4% increase in CnF sales volumes. Margins in the fourth quarter were lower by 4.1% resulting primarily from higher freight costs and field services costs associated with the start-up of our new PCM service line, increased citrus terpene cost and a product mix. Margins are expected to recover during 2017 as the company implements price increases, product reformulations and optimizes our PCM service offering. Although year-over-year energy chemistry technology revenue decreased 11.9%, gross margin increased 1.2 percentage points. Most notably, CnF sales volumes increased 14.7% year-over-year which is impressive as this took place during the worst industry activity slump to date. This means the energy chemistry segment as a whole clearly outperformed the broader completion market as key sales volumes rose despite U.S. well completions plunging by more than a third in 2016. CnF has and will remain a consistent and significant percentage of revenue. Flotek clients' are reporting success raising EURs or expected ultimate recovery using our patented chemistry technologies that facilitate better flows in conventional and unconventional wells. A growing number of operators in the Permian Basin of Texas have spoken to investors recently about their successful use of nano-Fluids and their plans to use them in a larger number of wells. More specifically, we would like to congratulate two of our clients, Brigham Resources and Silverback Exploration for their recent asset sales in the Delaware Basin. Brigham in particular worked with us to determine the optimum concentration amount of CnF by changing only the CnF concentration in their completion recipe for multiple wells. All other variables in the completion technique including perforation design, proppant concentration, flow back rates etcetera, were held constant while testing concentration of CnF up to 2.5 gallons per 1000 gallons of fluid pumped. Though an economic analysis in this case proved that more is not necessarily the optimum strategy, Brigham observed their maximum return at 1.5 gallons per 1000 and it was clearly evident that the CnF was superior to other industry products and was a significant contributor to their expected ultimate recovery uplift. To quote, Eric Hoover, Brigham's Executive Vice President of Operations, Flotek's nano technology was a game changer for us in the Southern Delaware Basin, without a doubt it was an important driver in making our Pecos County acreage a huge success. Silverback has also been one of our premiere clients and we would like to congratulate them as well on their recent transaction of selling their acreage in company. Their COO, Steve Lipari, sent me a note thanking us for the collaboration between our two organizations. Steve specifically felt that our prescriptive chemistry approach used in their completion program was important in maximizing their expected ultimate recovery. Silverback took the time to use chemical tracers to help validate our chemistry prescriptions and were also open to using CnF in non-traditional applications in their completion process that will benefit us and our clients in the future. Their technical curiosity created a true chemistry experience that benefited both of us. Consumer and industrial chemistry technologies or CICT reported record revenue of $74.6 million, up 32.3% year-over-year. Importantly, we received ISO certification for food grade activities and added two small distillation units to expand our capacity and variability to manufacture high flavor compounds. Increased costs for raw materials drew down our quarterly gross profit by 32%, but our gross profit for the year increased by $1.7 million or 11.9% from 2015. Drilling technologies had the best quarter of the entire year with revenue up 5.6% from Q3 to Q4 though as part of our ongoing plans to transform our business, we have an active divestiture process under way and are now treating the business as a discontinued operation for our financial reporting purposes. Rich will have more on that in just a moment. Revenue for our production technologies segment increased 5.3% sequentially to the highest quarter of the year, while gross margin for the year was down 12.1%. Quarterly margins grew by 4.4% on increased revenue and improved pricing. This segment is also treated as a discontinued operation for financial reporting purposes. I would also like to note that despite our decision to discontinue these two segments, our team managed to deliver special results for the quarter exhibiting the utmost work ethic and professionalism. The Flotek Store continues to drive transparency in the market for accurate pricing of prescriptive chemistry solutions. We are pleased to tell you that about 40% of our energy chemistry and revenue now comes through the virtual store. The store brings us closer to our clients while offering them greater control and direct benefits. When I reflected on 2016, I am proud that despite the most significant activity downturn ever in both depth and duration, Flotek has done remarkably well by continuing to grow sales volumes of products during each succeeding quarter of 2016 at a pace that has outperformed changes in activity levels in the broader U.S. onshore market. I will now turn it over to our CFO, Rich Walton, to deliver our financial results. Rich?